DigestRedComo funciona
Red
/
Empresas
Ki
No verificado

Kivu Bioscience

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosOncologíaSalud

9 Comunicados de prensa

Ver todos los comunicados de prensa
14/04/2026
Eventos
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Kivu Bioscience to Present Preclinical Data on Next-Generation ADC Programs at AACR Annual Meeting 2026
Fuente
Kivu Bioscience
Editor
Business Wire
1.00
0
14/04/2026
Kivu Bioscience Appoints Mohit Trikha, Ph.D., as Chief Executive Officer
Fuente
Kivu Bioscience
Editor
Business Wire
1.00
0
03/03/2026
Kivu Bioscience Appoints Brunilda Shtylla as Chief Business Officer
Fuente
Kivu Bioscience
Editor
Business Wire
1.00
0
27/01/2026
Kivu Bioscience Appoints Julie Hambleton, M.D., to its Board of Directors
Fuente
Kivu Bioscience
Editor
Business Wire
1.00
0
12/01/2026
Industria
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Oncología
Kivu Bioscience Announces First Patient Dosed in Phase 1 Trial of KIVU-107 Next-Generation PTK7-Targeting ADC for Advanced Solid Tumors
Fuente
Kivu Bioscience
Editor
Business Wire
1.00
0
27/10/2025
Kivu Bioscience Appoints Sophia Randolph, M.D., Ph.D., as Chief Medical Officer
Fuente
Kivu Bioscience
Editor
Business Wire
1.00
0
20/10/2025
Oncología
Salud
Sanidad
Medicina - Varios
Farmacéutica
Biotecnología
Eventos
Industria
Kivu Bioscience Presents Preclinical Data for KIVU-107 Demonstrating Potent and Durable Anti-Tumor Activity and a Wide Therapeutic Index at World ADC San Diego 2025
Fuente
Kivu Bioscience
Editor
Business Wire
1.00
0
02/06/2025
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Oncología
Mercado laboral
Kivu Bioscience Selects Sterling Pharma Solutions for cGMP Manufacturing of Lead Oncology Antibody-Drug Conjugate KIVU-107
Fuente
Kivu Bioscience
Editor
Business Wire
1.00
0
28/10/2024
Ciencia
Biotecnología
Medicina - Varios
Salud
Farmacéutica
Oncología
Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates
Fuente
Kivu Bioscience
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0